Related Experiment Video
Updated: Sep 8, 2025

11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
12.7K
A Real-World Experience in Pan-Tumor Testing for HER2 IHC in More Than 65 000 Solid Tumors
Dave Bryant1, Rebecca Feldman1, Farah Abdulla1
1Caris Life Sciences, Phoenix, Arizona.
JAMA Oncology
|June 26, 2025
Abstract
No abstract available in PubMed .

